Cardiovascular disease/stroke risk stratification in deep learning framework: a review.

Authors:
Bhagawati M; Paul S; Agarwal S; Protogeron A; Sfikakis PP and 21 more

Journal:
Cardiovasc Diagn Ther

Publication Year: 2023

DOI:
10.21037/cdt-22-438

PMCID:
PMC10315429

PMID:
37405023

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Cardiovasc Diagn Ther

Abbreviation: Cardiovasc Diagn Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiac & Cardiovascular Systems

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Dipeptidyl peptidase-4 inhibitors versus sulfonylureas on the top of metformin in patients with dia…
Her AY; Choi BG; Rha SW and 3 more (2024) - Transparency Score: 3/6
Discrimination models with radiomics features derived from cardiovascular magnetic resonance images…
Zhang H; Tian J; Zhang C and 7 more (2024) - Transparency Score: 3/6
Doppler echocardiography for surveillance of acute cardiac allograft rejection: a 28-year single-ce…
Vallée A; Houyel L; To NT and 13 more (2024) - Transparency Score: 3/6
M<sub>3</sub> subtype of muscarinic acetylcholine receptor inhibits cardiac fibrosis via targeting …
Li W; Yu J; Yang Y and 6 more (2024) - Transparency Score: 3/6
Right ventricle to pulmonary artery conduit: a comparison of long-term graft-related events between…
Helal AM; Mashali MH; Elmahrouk AF and 3 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://cdt.amegroups.com/article/view/10.21037/cdt-22-438/coif). IMS is on the clinical advisory board of AtheroPoint™, Roseville, CA, USA. LS serves as an unpaid editorial board member of Cardiovascular Diagnosis and Therapy from September 2021 to August 2023. JSS is with AtheroPointTM, Roseville, CA, USA, focusing in the area of Stroke and Cardiovascular Imaging. The other authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding: None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025